Immature oocyte retrieval combined with in-vitro oocyte maturation
|
|
- Annabella Bryant
- 6 years ago
- Views:
Transcription
1 Immature oocyte retrieval combined with in-vitro oocyte maturation J.B.Russell The Center for Human Reproduction, 4745 Ogletown Stanton Road, Suite 111, Newark, DE 19713, USA Immature oocyte retrieval combined with in-vitro oocyte maturation has a considerable potential to increase knowledge on the microenvironment and nuclear and cytoplasmic maturation, and may be an alternative or even replacement for routine in-vitro fertilization as practised today. Understanding the critical steps to accomplish this task demands ongoing research to produce a comparable microenvironment to that of the developing follicle. This will allow cytoplasmic maturation to occur, and clarify knowledge on the selection of the dominant follicle, and utilize novel aspects fertilization and embryo culture in vitro. A second aspect of the procedure concerns its clinical aspects. These include a better understanding of the number of antral follicles that can be retrieved transvaginally and the nature of the endometrial window and its advancement in order to provide a window of opportunity for implantation to occur. Key words: embryo transfer/endometrial priming/immature oocytes/in-vitro fertilization/in-vitro maturation Introduction Since the momentous birth of Louise Brown in 1978, the focus of assisted reproductive technology (ART) has been on securing numerous mature oocytes prior to their removal from the ovary (Laufer et al, 1983; Pellicer et al, 1989). This procedure allows optimal in-vivo oocyte maturation prior to their retrieval, challenging the laboratory to accomplish fertilization and early embryonic division prior to their transfer and hopefully implantation to the endometrial cavity. The past decade of refinements have evolved with the oocyte retrieval process moving toward a more simplified, minimally invasive transvaginal ultrasound-guided aspiration combined with extremely technological advanced fertilization procedures, such as intracytoplasmic sperm injection (ICSI) (Russell et al, 1986; Palermo et al, 1992). Laboratory culture techniques have examined a variety of conditions including different media preparations with or without serum supplementation, different media enhancing additives, and the controversial use of co-culture techniques Human Reproduction Volume 13 Supplement European Society for Human Reproduction and Embryology 63
2 .I.B.Russell (Menezo et al, 1984; Sakkas et al, 1994; Tarin et al, 1994; McWilliams et al, 1995; Magli et al, 1996). Clinically, ovulation induction protocols have focused on enhancing recruitment of the cohort of follicles and synchronizing their development by down-regulation of the central axis using gonadotrophin-releasing hormone (GnRH) agonists (Porter et al, 1984; Meldrum et al, 1989). All of these factors have added to our ability to offer in-vitro fertilization (IVF) to numerous patients with multiple diagnoses with gradually improving clinical pregnancy rates. A process introduced several years ago in animal studies utilized in-vitro oocyte maturation as a supply of mature oocytes. This practice was then introduced into human clinical trials during the early days of IVF (Edwards et al, 1965; Tsuji et al, 1985.) This procedure has been successful in producing live born offspring in animals (Goto et al, 1988; Keskintepe et al, 1994), and in humans (Cha et al, 1991; Trounson et al, 1994; Barnes et al, 1995; Russell et al, 1997). The challenge with human in-vitro oocyte maturation is to provide optimal conditions for in-vitro maturation by mimicking the microendocrine environment of the developing follicle to enable the immature oocyte to achieve nuclear and cytoplasmic maturation. Once oocyte maturation in vitro has been completed, fertilization and culture conditions must also be optimal prior to the transfer of embryos to the uterus for implantation to take place. Initial studies leading up to the first birth from an unstimulated immature oocyte retrieval used surgically-removed ovarian specimens (Cha et al, 1991). The ovary was then dissected for the identification of antral follicles in the laboratory prior to the oocytes being matured and fertilized. The fertilized oocytes were then frozen, thawed, and transferred to a host uterus in which a triplet gestation was obtained and delivered. Trounson et al. (1994) reported their clinical experience with performing invitro oocyte maturation after transvaginal ultrasound guidance in anovulatory and ovulatory patients with polycystic ovarian (PCO) disease. PCO patients are excellent candidates for transvaginal immature oocyte retrieval due to their ovarian size and numerous arrested early antral follicles in the range 5-8 mm. In addition, oocyte maturation offers them an alternative to the associated complications encountered by PCO patients during controlled ovarian hyperstimulation. Problems with overall oocyte quality associated with polycystic ovarian disease patients include a compromised quality of oocytes and a toxic luteinizing hormone (LH) secretion due to the elevated androgen microenvironment in the patients (Anderiesz et al, 1995). A significant part of Trounson's clinical achievement with human in-vitro oocyte maturation was the ability to retrieve immature oocytes transvaginally in polycystic ovarian disease patients, mature them in vitro, fertilize them with direct insemination and transfer the embryo to the uterus in the cycle in which the oocytes were retrieved. This innovative technique ended with the conception and delivery of a child born in 1994 (Trounson et al, 1994). The clinical features of this successful procedure were the transvaginal retrieval of oocytes from the ovary, and replacement of the embryos into a uterus which had to be prepared 64
3 In-vitro oocyte maturation in a very short period of time. This was accomplished by the administration of exogenous oestrogen and progesterone after oocyte retrieval. The purpose of this paper is to assess the clinical ability to retrieve, mature, and fertilize immature oocytes retrieved from patients who are ART candidates with different diagnoses. Methods and materials Patients with different diagnoses who had failed a previous IVF cycle were enrolled in the immature oocyte retrieval programme. Patients signed an informed consent before the procedure. The patient was assessed on cycle day 2 or 3 using baseline levels of follicle stimulating hormone (FSH), oestradiol and progesterone. A baseline ultrasound was also performed to assess and quantify early follicular development, and rule out any residual pathology. Follicles were measured on either day 6, 7, or 8 by ultrasound and compared to the number of immature oocytes retrieved on days The retrieval was scheduled between day 9 and day 12. If a dominant follicle (^1.3 cm) was visualized by ultrasound by day 8 or at the time of the retrieval, the procedure was cancelled and rescheduled earlier in the next month. Oocyte retrieval Oocyte retrieval was performed transvaginally with ultrasound guidance. The retrieval of immature oocytes is very similar to the retrieval of mature oocytes from stimulated follicles. The vaginal vault was cleansed with antibacterial soap and sterile water. A paracervical block was administered with 1% lidocaine and the vaginal vault was then filled with culture media. The sterile biopsy guide and a 5 MHz trans vaginal probe was inserted into the lateral fornix. An ultrasound evaluation was performed and all follicles identified as 6-12mm were punctured using mm Hg pressure until all follicular contents including fluid and cells were curetted from the follicle. The fluid was collected without flushing the follicle into a test tube with 3 ml of culture media maintained at 37 C. All patients undergoing oocyte retrieval received i.v. sedation with Fentanyl (Elkins- Sinn Inc, A.H.Robbins), Versed (Roche Laboratories), and Propofol (Zeneca). All of the follicles sized ^6 mm were aspirated. The needle was a 17 gauge, 30 cm long Cook aspiration needle with a needle with a short bevel. An Emcon embryo filter unit (75 pin, Veterinary Concepts, Spring Valley,WI, USA) was primed with at least 10 ml of heparinized modified human tubal fluid (M-HTF) (Irvine Scientific, Irvine, CA, USA) prior to the first aspirate. When the follicular fluid was obtained, it was filtered by gravity and rinsed with additional M-HTF to remove any red blood cells. The fluid remaining after filtration was decanted into Petri dishes which were scanned under a stereomicroscope for the identification of immature oocytes. These immature oocytes were graded and placed into Falcon tubes with M-HTF and 3% synthetic serum 65
4 J.B.Russell supplement (SSS) (Irvine Scientific). The immature oocytes, once graded, were placed in maturation media. The base maturation media consisted of tissue culture media (TCM 199) (Sigma Chemical, St Louis, MO, USA) with fetal calf serum (10%), urinary human FSH (0.075 IU) (Serono, Randolph, MA, USA) 17p-oestradiol (1 (ag/ml) (Sigma) and human chorionic gonadotrophin (0.5 IU) (Steris, Phoenix, AZ, USA). Immature oocytes were allowed to mature over the next 48 h. They were examined every 12 h and those with extruded a polar body at the end of this 48 h period were prepared for insemination. ICSI was performed to eliminate male factor bias on oocytes that matured without significant retraction, vacuolization or fragmentation. Normally fertilized oocytes were then transferred to culture media with Vero cells for co-culture. Embryo transfer was performed 2-3 days after insemination. Morphology of retrieved oocytes Three types of oocytes were retrieved from the ovary during the retrieval of immature oocytes. These categories were compact, bald, and atretic. Compact immature oocytes possessed 1-2 layers and occasionally 4-5 layers of corona cells overlying the oocyte. Bald oocytes had very few corona cells covering the zona pellucida and were void of any continuity with these cells. Endometrial priming Endometrial priming consisted of a model typical of mid- to late follicle priming. Exogenous hormones were used for this purpose. Oestradiol valerate (i.m.) or micronized 17(3-oestradiol (PO) was started 1-3 days prior to oocyte aspiration. Progesterone ( mg i.m.) was initiated 1-2 days after oocyte retrieval. Results Patients (n = 37) who were candidates for ART underwent the immature oocyte retrieval process. Their mean age was 34.7 ± 4.6 years, range Their diagnoses included tubal disease (n = 9), endometriosis (n = 7), anovulation (n = 11), male factor (n = 6), and unexplained (n = 4). FSH concentrations on cycle day 2 or 3 were 7.4 ± 3.9 mlu/ml. LH concentrations were 9.1 ± 5.2 mlu/ml, and baseline oestradiol 43 ± 15.5 pg/ml. Oocytes were retrieved from all patients who underwent immature oocyte retrieval, and a total of 431 immature eggs were collected (11.6/patient). The correlation between age and the number of oocytes is shown in Figure 1. A total of 28 patients underwent ultrasound evaluation on cycle days 6, 7, or 8 when all follicles ^6 mm were measured; the number of follicles was compared with the number of oocytes retrieved. The retrieval efficiency was 86.4% from 302 follicles sized s=6-12 mm and
5 In-vitro oocyte maturation 1 Total = 431 oocytes Average =ll.l/pt t Age Figure 1. Relationship between maternal age and the number of immature oocytes retrieved Total: 431 oocytes 70 H ^ 60 If ^ i198/ /431 77/431 Compact Bald Atretic Figure 2. Ratios of different forms of immature oocytes that were retrieved and their corona cell complexes. immature oocytes retrieved. A classifcation of the morphology of the first 431 aspirated oocytes is shown in Figure 2. The ratio of bald:compact:atretic oocytes was (156/431) 36%: (198/431) 46%: (77/431) 18%. The overall maturation rate was 63% (223/354) with no significant difference between bald and compact oocytes (P ^0.05). The fertilization rate was similar between bald and compact oocytes, being overall 72% (160/223). The proportion of oocytes with two pronuclei (2PN), as a percentage of all those injected, was 67%. Abnormal fertilization or eggs with ^3PN, were observed in 6% (10/160) of the oocytes and 5% were damaged, i.e. eight of the 160 oocytes injected. Comparisons between compact and bald oocytes revealed a very similar rate of maturation and fertilization, although the cleavage rate appeared to favour oocyte that were morphologically graded as compact at the time of their retrieval. 67
6 .J.B.Russell Our present retrieval time averages ~36 min. In al 81% (30/37) of the patients had an embryo transfer. Discussion Our initial study revealed a significant decrease in rates of oocyte maturation and cleavage rates of embryos exposed to early exogenous oestrogen prior to retrieval (Russell, 1997). Although the uterus was primed sufficiently for implantation to take place, oocyte quality and cleavage dramatically decreased when the oocytes were exposed to exogenous oestrogen early in the cycle. Further refinements are clearly needed to advance the endometrial environment from a day 9 or 10 follicular-phase endometrium to a day 19 or 20 endometrium within a 5 day timetable. Navot et al. (1989) showed how patients with a short exposure to exogenous oestrogens had a higher spontaneous abortion rate. In our study, immature oocytes must undergo a competent cytoplasmic maturation, and embryos must be able to implant at an acceptable rate. These processes must be synchronized if implantation is to occur. The luteal phase must be supported with enough exogenous oestrogen and progesterone support to maintain a secretory endometrium until the pregnancy test is performed. If a pregnancy is established, the exogenous hormonal administration is continued until the placenta functions independently. Endometrial priming is a significant aspect of this procedure. It will impact on the success and ability to retrieve immature oocytes, and must be combined with in-vitro oocyte maturation to become a clinical therapy for those couples attempting to conceive using assisted conception. The challenge is to retrieve immature oocytes from the ovary in the mid- to late follicular phase and then return them to the implantation cavity 4-5 days later. The endometrium presumably has an endometrial 'window' which opens at day after an incomplete follicular phase exposure to oestrogen and a very short exposure to progesterone. During the final selection of the dominant follicle, there appears to be a critical point where the selection process has a negative effect on the maturation of existing follicles containing immature oocytes. This point apparently involves an increased rate of atresia among those follicles not selected to ovulate. Our early experience has shown a dramatic decrease in the rates of maturation, fertilization and transfer among cycles in which immature eggs were retrieved when a dominant follicle (5=1.4 cm) was present at the time of retrieval. The key to timing the retrieval of immature oocytes is to allow endogenous gonadotrophins to enhance an early recruitment and to initiate early cytoplasmic and possibly nuclear maturation, which can be completed in vitro. The future of in-vitro oocyte maturation as a therapy for couples attempting to conceive by means of assisted conception has enormous potential. It can alleviate the medication required to recruit the cohort of follicles in the month of aspiration, eliminate medications, reduce the risks of hyperstimulation and the long-term theoretical implications of ovarian cancer. The economic impact is
7 In-vitro oocyte maturation also profound, since there is a sharp reduction in the numbers of repeated laboratory studies and ultrasound analyses required for monitoring. It is also beneficial in relation to the patients' time required to perform these studies. In addition, an initial diagnostic laparoscopic procedure permits the retrieval of immature eggs for diagnostic purposes and an assessment of oocyte quality. It also allows the patient the potential of a conception in the early stages of their workup. The retrieval of immature oocytes combined with in-vitro oocyte maturation' for women in an oocyte donation programme, will appeal to individuals concerned about the administration of gonadotrophins, and of any potential short- and long-term side effects. Understanding cytoplasmic and nuclear maturation may provide information on the spontaneous chromosomal abnormalities frequently associated with recurrent pregnancy loss. References Anderiesz, C. and Trounson, A.O. (1995) The effect of testosterone on the maturation and developmental capacity of murine oocytes in vitro. Hum. Reprod., 10, Barnes, F.L., Crombie A., Gardner D.K. et al. (1995) Blastocyst development and birth after invitro maturation of human primary oocytes, intracytoplasmic sperm injection and assisted hatching. Hum. Reprod., 10, Cha, K.Y., Koo, J.J., Ko, J.J. et al. (1991) Pregnancy after in vitro fertilization of human follicular oocytes collected from nonstimulated cycles, their culture in vitro and their transfer in a donor oocyte program. Fertil. Steril, 55, Edwards, R.G. (1965) Maturation in vitro of mouse, sheep, cow, pig, rhesus monkey and human ovarian oocytes. Nature, 58, Goto, K., Kajihara, Y., Kosaka, S. et al. (1988) Pregnancies after co-culture of cumulus cells with bovine embryos derived from in vitro fertilization of in vitro matured follicular oocytes. J. Reprod. Fertil, 83, Keskintepe, L., Darwish, A.T. et al. (1994) Term development of caprine embryos derived from immature oocytes in vitro. Theriogenology, 42, Laufer, N., DeCherney, A.H., Haseltine, F.P. et al. (1983) The use of high-dose human menopausal gonadotropin in an in vitro fertilization program. Fertil. Steril., 40, Magli, M.C., Gianaroli, L., Fiorentino, A.P. et al. (1996) Improved cleavage rate of human embryos cultured in antibiotic-free medium. Hum. Reprod., 11, McWilliams, R.B., Gibbons, W.E. and Leibo, S.P. (1995) Osmotic and physiological responses of mouse zygotes and human oocytes to mono- and disaccharides. Hum. Reprod., 10, Meldrum, D.R., Wisot, A., Hamilton, F. et al. (1989) Routine pituitary suppression with leuprolide before ovarian stimulation for oocyte retrieval. Fertil. Steril., 51, 455^459. Menezo, Y., Testart, J. and Perrone, D. (1984) Serum is not necessary in human in vitro fertilization, early embryo culture and transfer. Fertil. Steril., 42, Navot, D., Anderson, T.L., Droesch, K. et al. (1989) Hormonal manipulation of endometrial maturation. J. Clin. Endocrinol. Metab., 68, Palermo, G., Joris, H., Devroey, P. et al. (1992) Pregnancies after intracytoplasmic injection of a single spermatozoon into an oocyte. Lancet, 340, 17-18, Pellicer, A., Ruiz, A., Castellvi, R.M. et al. (1989) Is the retrieval of high numbers of oocytes desirable in patients treated with gonadotrophin-releasing hormone analogues (GnRHa) and gonadotrophins? Hum. Reprod., 4, Porter, R.N., Smith, W., Craft, J.L. et al. (1984) Induction of ovulation for in vitro fertilization using busurelin and gonadotrophins. Lancet, ii, Regan, L., Owen, E.J. and Jacobs, H.S. (1990) Hypersecretion of luteinizing hormone, infertility, and miscarriage. Lancet, 336,
8 J.B.Russell Russell, J.B., DeCherney, A.H. and Hobbins, J.C. (1985) The new transvaginal probe and biopsy guide for oocyte retrieval. Fertil. Steril., 47, Russell, J.B., Knezevich, K.M., Fabian, K.F. et al. (1997) Unstimulated immature oocyte retrieval: early versus midfollicular endometrial priming. Fertil. Steril., 67, Sakkas, D., Jaquenoud, N., Leppens, G. et al. (1994) Comparison of results after in vitro fertilized human embryos are cultured in routine medium and in coculture on Vero cells: a randomized study. Fertil. Steril, 61, Tarin, J.J., de los Santos, M.J., de Oliveira, M.N.M. et al. (1994) Ascorbate-supplemented media in short-term cultures of human embryos. Hum. Reprod., 9, Trounson, A., Wood, C. and Kausche, A. (1994) In vitro maturation and the fertilization and developmental competence of oocytes recovered from untreated polycystic ovarian patients. Fertil. Steril., 62, Tsuji, K., Sowa, M. and Nakano, R. (1985) Relationship between human oocyte maturation and different follicular sizes. Biol. Reprod., 32,
Oocyte maturation. A.Trounson 1 ' 3, C.Anderiesz 1, G.MJones 1, A.Kausche 1, N.Lolatgis 2 and C.Wood 2
A.Trounson 1 ' 3, C.Anderiesz 1, G.MJones 1, A.Kausche 1, N.Lolatgis 2 and C.Wood 2 Centre for Early Human Development, Institute of Reproduction and Development, Monash University, Monash Medical Centre,
More informationPossible factors affecting the development of oocytes in in-vitro maturation
Human Reproduction Vol. 15, (Suppl. 5) pp. 11-17, 2000 Possible factors affecting the development of oocytes in in-vitro maturation Anne Lis Mikkelsen 1 ' 2, Steven Smith 1 and Svend Lindenberg 1 ^he Fertility
More informationIVM in PCOS patients. Introduction (1) Introduction (2) Michael Grynberg René Frydman
IVM in PCOS patients Michael Grynberg René Frydman Department of Obstetrics and Gynecology A. Beclere Hospital, Clamart, France Maribor, Slovenia, 27-28 February 2009 Introduction (1) IVM could be a major
More informationArticle Effect of gonadotrophin priming on in-vitro maturation of oocytes collected from women at risk of OHSS
RBMOnline - Vol 13. No 3. 2006 340 348 Reproductive BioMedicine Online; www.rbmonline.com/article/2328 on web 12 June 2006 Article Effect of gonadotrophin priming on in-vitro maturation of oocytes collected
More informationLOW RESPONDERS. Poor Ovarian Response, Por
LOW RESPONDERS Poor Ovarian Response, Por Patients with a low number of retrieved oocytes despite adequate ovarian stimulation during fertility treatment. Diagnosis Female About Low responders In patients
More informationInfertility treatment
In the name of God Infertility treatment Treatment options The optimal treatment is one that provide an acceptable success rate, has minimal risk and is costeffective. The treatment options are: 1- Ovulation
More informationFavourable pregnancy results with insemination of in vitro matured oocytes from unstimulated patients
Human Reproduction Vol.20, No.6 pp. 1534 1540, 2005 Advance Access publication February 3, 2005 doi:10.1093/humrep/deh768 Favourable pregnancy results with insemination of in vitro matured oocytes from
More informationInfertility. Review and Update Clifford C. Hayslip MD Intrauterine Inseminations
Infertility Review and Update Clifford C. Hayslip MD Intrauterine Inseminations Beneficial effects of IUI not consistently documented in studies No deleterious effects on fertility 3-4 cycles of IUI should
More informationI. ART PROCEDURES. A. In Vitro Fertilization (IVF)
DFW Fertility Associates ASSISTED REPRODUCTIVE TECHNOLOGY (ART) Welcome to DFW Fertility Associates/ Presbyterian-Harris Methodist Hospital ARTS program. This document provides an overview of treatment
More informationFemale Reproductive Physiology. Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF
Female Reproductive Physiology Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF REFERENCE Lew, R, Natural History of ovarian function including assessment of ovarian reserve
More informationAssisted Reproduction. By Dr. Afraa Mahjoob Al-Naddawi
Assisted Reproduction By Dr. Afraa Mahjoob Al-Naddawi Learning Objectives: By the end of this lecture, you will be able to: 1) Define assisted reproductive techniques (ART). 2) List indications for various
More informationOriginal Article Impact of estrogen-to-oocyte ratio on live birth rate in women undergoing in vitro fertilization and embryo transfer
Int J Clin Exp Med 2015;8(7):11327-11331 www.ijcem.com /ISSN:1940-5901/IJCEM0008838 Original Article Impact of estrogen-to-oocyte ratio on live birth rate in women undergoing in vitro fertilization and
More informationBiology of fertility control. Higher Human Biology
Biology of fertility control Higher Human Biology Learning Intention Compare fertile periods in females and males What is infertility? Infertility is the inability of a sexually active, non-contracepting
More informationFertility 101. About SCRC. A Primary Care Approach to Diagnosing and Treating Infertility. Definition of Infertility. Dr.
Dr. Shahin Ghadir A Primary Care Approach to Diagnosing and Treating Infertility St. Charles Bend Grand Rounds November 30, 2018 I have no conflicts of interest to disclose. + About SCRC State-of-the-art
More informationThe reproductive lifespan
The reproductive lifespan Reproductive potential Ovarian cycles Pregnancy Lactation Male Female Puberty Menopause Age Menstruation is an external indicator of ovarian events controlled by the hypothalamicpituitary
More informationINDICATIONS OF IVF/ICSI
PROCESS OF IVF/ICSI INDICATIONS OF IVF/ICSI IVF is most clearly indicated when infertility results from one or more causes having no other effective treatment; Tubal disease. In women with blocked fallopian
More informationStudy on Several Factors Involved in IVF-ET of Human Beings
Study on Several Factors Involved in IVF-ET of Human Beings Lei X 1, Zhuoran W 1, Bin L 1, Huiming L 1, Hongxiu Z 1, Yajuan Z 1, Yingbo Q 1, Guixue Z 2 1 The First Clinical College of Harbin Medical University,
More informationPuerto Rico Fertility Center
Puerto Rico Fertility Center General Information of the In-Vitro Fertilization Program Dr. Pedro J. Beauchamp First test-tube baby IN PUERTO RICO Dr. Pedro Beauchamp with Adlin Román in his arms. Paseo
More informationClinical ICSI in the horse:
Clinical ICSI in the horse: differences and similarities to human in an in vitro maturation-based system Katrin Hinrichs College of Veterinary Medicine & Biomedical Sciences Texas A&M University Standard
More informationAssisted reproductive technology
Assisted reproductive technology FERTILITY AND STERILITY Vol. 60, No.2, August 1993 Copyright 'c; 199:~ The American Fertility Society Printed on acid-free paper in U. S. A. Natural cycle in vitro fertilization-embryo
More informationLuteal phase rescue after GnRHa triggering Progesterone and Estradiol
Luteal phase rescue after GnRHa triggering Progesterone and Estradiol L. Engmann University of Connecticut Disclaimer Fertility Speaker Bureau Merck Pharmaceuticals Introduction GnRH agonist is effective
More informationClinical Study Clinical Effects of a Natural Extract of Urinary Human Menopausal Gonadotrophin in Normogonadotropic Infertile Patients
International Reproductive Medicine Volume 2013, Article ID 135258, 4 pages http://dx.doi.org/10.1155/2013/135258 Clinical Study Clinical Effects of a Natural Extract of Urinary Human Menopausal Gonadotrophin
More informationNeil Goodman, MD, FACE
Initial Workup of Infertile Couple: Female Neil Goodman, MD, FACE Professor of Medicine Voluntary Faculty University of Miami Miller School of Medicine Scope of Infertility in the United States Affects
More informationLouise Brown born First IVF baby Born to Lesley Brown, bilateral tubal blockage Natural cycle, single egg fertilization
Louise Brown born First IVF baby Born to Lesley Brown, bilateral tubal blockage Natural cycle, single egg fertilization IVF 1878 - first reported attempts at IVF 1959 - IVF births in rabbits in USA 1968
More informationIN VITRO MATURATION OF HUMAN OOCYTES
REVIEW ARTICLE IN VITRO MATURATION OF HUMAN OOCYTES Yu-Hung Lin 1,2, Jiann-Loung Hwang 1,3 * 1 Department of Obstetrics and Gynecology, Shin Kong Wu Ho-Su Memorial Hospital, 2 School of Medicine, Fu Jen
More informationPatient Overview: Invitro Fertilisation
Patient Overview: Overview IVF stands for in-vitro fertilisation i.e. literally fertilisation in a glass dish. You may also hear the term ART used which stands for Assisted Reproductive Technologies. IVF
More informationThe effect of adding oral oestradiol to progesterone as luteal phase support in ART cycles a randomized controlled study
Clinical research The effect of adding oral oestradiol to progesterone as luteal phase support in ART cycles a randomized controlled study Ashraf Moini 1,2, Shahrzad Zadeh Modarress 3, Elham Amirchaghmaghi
More informationIn vitro maturation of human oocytes for assisted reproduction
MODERN TRENDS Edward E. Wallach, M.D. Associate Editor In vitro maturation of human oocytes for assisted reproduction Marcus W. Jurema, M.D., and Daniela Nogueira, Ph.D. Department of Obstetrics and Gynecology,
More informationIs it the seed or the soil? Arthur Leader, MD, FRCSC
The Physiological Limits of Ovarian Stimulation Is it the seed or the soil? Arthur Leader, MD, FRCSC Objectives 1. To consider how ovarian stimulation protocols work in IVF 2. To review the key events
More informationIn Vitro Fertilization in Clomiphene-Resistant Women with Polycystic Ovary Syndrome
Original Article Effect of Laparoscopic Ovarian Drilling on Outcomes of In Vitro Fertilization in Clomiphene-Resistant Women with Polycystic Ovary Syndrome Maryam Eftekhar, M.D. 1, Razieh Deghani Firoozabadi,
More informationMilder is better? Advantages and disadvantages of "mild" ovarian stimulation for human in vitro fertilization
Milder is better? Advantages and disadvantages of "mild" ovarian stimulation for human in vitro fertilization Revelli et al. Reproductive Biology and Endocrinology 2011, 9:25 Presenter: R2 孫怡虹 Background
More informationInterpreting follicular Progesterone: Late follicular Progesterone to Estradiol ratio is not influenced by protocols or gonadotropins used
Interpreting follicular Progesterone: Late follicular Progesterone to Estradiol ratio is not influenced by protocols or gonadotropins used Ellenbogen A., M.D., Shalom-Paz E., M.D, Asalih N., M.D, Samara
More informationProgesterone and clinical outcomes
Synchronization of Slowly Developing Embryos Restores Implantation Success Richard T. Scott, Jr, MD, HCLD Clinical and Scientific Director, Reproductive Medicine Associates of New Jersey Professor and
More informationA Tale of Three Hormones: hcg, Progesterone and AMH
A Tale of Three Hormones: hcg, Progesterone and AMH Download the Ferring AR ipad/iphone app from the Apple Store: http://bit.ly/1okk74m Interpreting Follicular Phase Progesterone Ernesto Bosch IVI Valencia,
More informationIn Vitro Fertilization What to expect
Patient Education In Vitro Fertilization What to expect This handout describes how to prepare for and what to expect when you have in vitro fertilization. It provides written information about this process,
More informationOptimal ICSI timing after the first polar body extrusion in in vitro matured human oocytes
Human Reproduction Vol.22, No.7 pp. 1991 1995, 2007 Advance Access publication on May 18, 2007 doi:10.1093/humrep/dem124 Optimal ICSI timing after the first polar body extrusion in in vitro matured human
More informationUnderstanding Infertility, Evaluations, and Treatment Options
Understanding Infertility, Evaluations, and Treatment Options Arlene J. Morales, M.D., F.A.C.O.G. Fertility Specialists Medical Group, Inc. What We Will Cover Introduction What is infertility? Briefly
More informationEndometrial Preparation for Frozen Embryo Transfer (FET) Zitao Liu, MD, PhD New Hope Fertility Center, NY
Endometrial Preparation for Frozen Embryo Transfer (FET) Zitao Liu, MD, PhD New Hope Fertility Center, NY Natural Cycle FET Protocol for endometrial preparation N FET, including modified N FET HRT FET:
More informationReproductive Endocrinology & Infertility Glossary
Reproductive Endocrinology & Infertility Glossary The following is a glossary of terms you may hear during your association with the University of Mississippi Health Care's reproductive endocrinology and
More informationComparison of serum and follicular fluid hormone levels with recombinant and urinary human chorionic gonadotropin during in vitro fertilization
Comparison of serum and follicular fluid hormone levels with recombinant and urinary human chorionic gonadotropin during in vitro fertilization Peter Kovacs, M.D., a Timea Kovats, M.D., a Artur Bernard,
More informationIVF AND PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) WHAT THE COMMUNITY PHYSICIAN NEEDS TO KNOW
IVF AND PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) WHAT THE COMMUNITY PHYSICIAN NEEDS TO KNOW Jon Havelock, MD, FRCSC, FACOG Co-Director - PCRM Disclosure No conflict of interest in relation
More information2017 United HealthCare Services, Inc.
UnitedHealthcare Pharmacy Clinical Pharmacy Programs Program Number 2017 P 1143-4 Program Prior Authorization/Notification Medication Menopur (menotropins) * P&T Approval Date 8/2014, 5/2015, 5/2016, 5/2017
More informationSynchronization between embryo development and endometrium is a contributing factor for rescue ICSI outcome
Reproductive BioMedicine Online (2012) 24, 527 531 www.sciencedirect.com www.rbmonline.com ARTICLE Synchronization between embryo development and endometrium is a contributing factor for rescue ICSI outcome
More informationFertilization of in vitro matured human oocytes by intracytoplasmic sperm injection (ICSI) using ejaculated and testicular spermatozoa
DOI: 10.1111/j.1745-7262.2005.00016.x. Original Article. Fertilization of in vitro matured human oocytes by intracytoplasmic sperm injection (ICSI) using ejaculated and testicular spermatozoa Yun Qian
More informationEmbryo Selection after IVF
Embryo Selection after IVF Embryo Selection after IVF Many of human embryos produced after in vitro fertilization carry abnormal chromosomes. Placing a chromosomally normal embryo (s) into a normal uterus
More informationIVF (,, ) : (HP-hMG) - (IVF- ET) : GnRH, HP-hMG (HP-hMG )57, (rfsh )140, (Gn)
34 11 Vol.34 No.11 2014 11 Nov. 2014 Reproduction & Contraception doi: 10.7669/j.issn.0253-3X.2014.11.0892 E-mail: randc_journal@163.com IVF ( 710003) : (H-hMG) - (IVF- ET) : GnRH H-hMG (H-hMG ) (rfsh
More informationInfertility: failure to conceive within one year of unprotected regular sexual intercourse. Primary secondary
Subfertility Infertility: failure to conceive within one year of unprotected regular sexual intercourse. Primary secondary Infertility affects about 15 % of couples. age of the female. Other factors that
More informationHonorary Fellow of the Royal College of Obs. & Gyn. First Indian to receive FIGO s Distinguished Merit Award for Services towards women s health.
Prof.Duru Shah Founder President The PCOS Society (India) President Elect of the Indian Society for Assisted Reproduction (ISAR) Honorary Fellow of the Royal College of Obs. & Gyn. First Indian to receive
More informationInfertility Clinical Guideline
Infertility Clinical Guideline Ovarian Stimulation Guideline Purpose: To provide sufficient background regarding various ovarian stimulation protocols for In Vitro Fertilization cycles. Goal: To assist
More informationPrinciples of Ovarian Stimulation
Principles of Ovarian Stimulation Dr Genia Rozen Gynaecologist and Fertility Specialist Royal Women s Hospital and Melbourne IVF Learning objectives Why ovarian stimulation Recap physiology Ovarian cycle
More informationAdoption and Foster Care
GLOSSARY Family building via Adoption and Foster Care October 2018 www.familyequality.org/resources A Anonymous Donor: A person who donated sperm or eggs with the intention of never meeting resulting children.
More informationAcupuncture Treatment For Infertile Women Undergoing Intracytoplasmic Sperm injection
Acupuncture Treatment For Infertile Women Undergoing Intracytoplasmic Sperm injection Sandra L. Emmons, MD Phillip Patton, MD Source: Medical Acupuncture, A Journal For Physicians By Physicians Spring
More informationExtended embryo culture in human assisted reproduction treatments
Human Reproduction Vol.16, No.5 pp. 902 908, 2001 Extended embryo culture in human assisted reproduction treatments M.T.Langley 1,3, D.M.Marek 1, D.K.Gardner 2, K.M.Doody 1 and K.J.Doody 1 1 Center for
More informationClinical consequences of ovarian stimulation in assisted conception and in PCOS Al-Inany, H.G.
UvA-DARE (Digital Academic Repository) Clinical consequences of ovarian stimulation in assisted conception and in PCOS Al-Inany, H.G. Link to publication Citation for published version (APA): Al-Inany,
More informationPhases of the Ovarian Cycle
OVARIAN CYCLE An ovary contains many follicles, and each one contains an immature egg called an oocyte. A female is born with as many as 2 million follicles, but the number is reduced to 300,000 to 400,000
More informationAgonist versus antagonist in ICSI cycles: a randomized trial and cost effectiveness analysis Badrawi A, Zaki S, Al-Inany H, Ramzy A M, Hussein M
Agonist versus antagonist in ICSI cycles: a randomized trial and cost effectiveness analysis Badrawi A, Zaki S, Al-Inany H, Ramzy A M, Hussein M Record Status This is a critical abstract of an economic
More informationLUTEAL PHASE SUPPORT. Doç. Dr. Nafiye Yılmaz. Zekai Tahir Burak Kadın Sağlığı Eğitim Araştırma Hastanesi
LUTEAL PHASE SUPPORT Doç. Dr. Nafiye Yılmaz Zekai Tahir Burak Kadın Sağlığı Eğitim Araştırma Hastanesi TAJEV, 2014 1 ART & success *Live birth rate 2 Optimal luteal phase Etiology of luteal phase deficiency
More informationSuperovulation with human menopausal gonadotropins is associated with endometrial gland-stroma dyssynchrony*
aes FERTILITY AND STERILITY Vol. 61, No.4, April 1994 Copyright ee) 1994 The American Fertility Society Printed on acid-free paper in U. S. A. r I Superovulation with human menopausal gonadotropins is
More informationFixed Schedule for in vitro Fertilization and Embryo Transfer: Comparison of Outcome between the Short and the Long Protocol
Yamanashi Med. J. 14(3), 77 ~ 82, 1999 Original Article Fixed Schedule for in vitro Fertilization and Embryo Transfer: Comparison of Outcome between the Short and the Long Protocol Tsuyoshi KASAI and Kazuhiko
More informationDoes triggering ovulation by 5000 IU of uhcg affect ICSI outcome? *
Middle East Fertility Society Journal Vol. 11, No. 2, 2006 Copyright Middle East Fertility Society Does triggering ovulation by 5000 IU of uhcg affect ICSI outcome? * Amany A.M. Shaltout, M.D. Mohamed
More informationSupraphysiological estradiol levels do not affect oocyte and embryo quality in oocyte donation cycles
Human Reproduction Vol.17, No.1 pp. 83 87, 2002 Supraphysiological estradiol levels do not affect oocyte and embryo quality in oocyte donation cycles Joseph E.Peña, Peter L.Chang 1, Lai-King Chan, Khaled
More informationIN VITRO FERTILISATION (IVF)
IN VITRO FERTILISATION (IVF) Pre Treatment - first cycle 785 Medical Consultation 225 Nurse Planning 235 Baseline ultrasound scan of uterus and ovaries HIV, Hep B antibodies, Hep B antigen, Hep C blood
More information10.7 The Reproductive Hormones
10.7 The Reproductive Hormones December 10, 2013. Website survey?? QUESTION: Who is more complicated: men or women? The Female Reproductive System ovaries: produce gametes (eggs) produce estrogen (steroid
More informationBlastocyst culture and transfer increases the efficiency of oocyte donation
FERTILITY AND STERILITY VOL. 74, NO. 3, SEPTEMBER 2000 Copyright 2000 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Blastocyst culture
More informationWOMEN & INFANTS HOSPITAL Providence, RI CONSENT FOR IVF WITH EMBRYO TRANSFER
*40639* 40639 WOMEN & INFANTS HOSPITAL Providence, RI 02905 CONSENT FOR IVF WITH EMBRYO TRANSFER I have requested treatment by the physicians and (Print Patient s name) staff of the Women & Infants Fertility
More informationIVF Protocols: Hyper & Hypo-Responders, Implantation
IVF Protocols: Hyper & Hypo-Responders, Implantation Midwest Reproductive Symposium June 4-5, 4 2010 Subset : Hyper-Responders Mark R. Bush, MD, FACOG, FACS OBJECTIVE: Important goals for the PCOS patient
More informationOutlook Strategies in human in-vitro maturation and their clinical outcome
RBMOnline - Vol 10. No 5. 2005 593 599 Reproductive BioMedicine Online; www.rbmonline.com/article/1677 on web 11 March 2005 Outlook Strategies in human in-vitro maturation and their clinical outcome Dr
More informationA new set of consent documents is required for each IVF attempt. CRM staff is available to answer your questions related to the consent documents.
Informed Consent Packet - In Vitro Fertilization (IVF) This packet contains the required IVF treatment consent documents. Please read, consider and, if you agree, sign and return the attached documents.
More informationIn Vitro Fertilization and Embryo Transfer
Acta Medica et Biologica Vol. 41, No.4, 171-176, 1993 The Influence of Low Ovarian Response on the Results of In Vitro Fertilization and Embryo Transfer Hirofumi HIRASAWA Department of Obstetrics and Gynecology,
More informationIn Vitro Fertilization
Patient Education In Vitro Fertilization About the treatment This handout describes how to prepare for and what to expect when you have in vitro fertilization. It provides written information about this
More informationKisspeptin: A Potential Factor for Unexplained Infertility and Impaired Embryo Implantation
Original Article Kisspeptin: A Potential Factor for Unexplained Infertility and Impaired Embryo Implantation Aaida Mumtaz, MBBS. 1#, Aqsa Khalid, MBBS. 1#, Zehra Jamil, M.Phil. 2, Syeda Sadia Fatima, Ph.D.
More informationFertility assessment and assisted conception
Fertility assessment and assisted conception Dr Geetha Venkat MD FRCOG Director Pulse Learning Women s health 14 September 2016 Disclosure statement Dr Venkat is a director of Harley Street Fertility Clinic.
More informationAge and Fertility. A Guide for Patients Revised 2012 Copyright 2012 by the American Society for Reproductive Medicine
1 Age and Fertility A Guide for Patients Revised 2012 Copyright 2012 by the American Society for Reproductive Medicine INTRODUCTION Fertility changes with age. Both males and females become fertile in
More informationIVF Patient Information
What is IVF? IVF (In Vitro Fertilisation) is a treatment by which fertilisation of eggs by sperm takes place outside the body in a dish in an IVF laboratory. An ovary has a pool of immature eggs. In a
More informationIndependent Review of Assisted Reproductive Technologies
Assisted Reproductive Technologies Review Committee Report of the Independent Review of Assisted Reproductive Technologies APPENDICES Assisted Reproductive Technologies Review Committee APPENDIX A February
More informationOutline. Male Reproductive System Testes and Sperm Hormonal Regulation
Outline Male Reproductive System Testes and Sperm Hormonal Regulation Female Reproductive System Genital Tract Hormonal Levels Uterine Cycle Fertilization and Pregnancy Control of Reproduction Infertility
More informationHold On To Your Dreams
Hold On To Your Dreams Dr. Michael Kettel Dr. Sandy Chuan 1. THE BASICS OF IVF & EMBRYO DEVELOPMENT 2. IVF ADD-ONS - MYTH VS. SCIENCE IN VITRO FERTILIZATION 1. Ovarian Stimulation 2. Egg Retrieval 3. Create
More informationDr Manuela Toledo - Procedures in ART -
Dr Manuela Toledo - Procedures in ART - Fertility Specialist MBBS FRANZCOG MMed CREI Specialities: IVF & infertility Fertility preservation Consulting Locations East Melbourne Planning a pregnancy - Folic
More informationDoes previous response to clomifene citrate influence the selection of gonadotropin dosage given in subsequent superovulation treatment cycles?
J Assist Reprod Genet (26) 23:427 431 DOI 1.17/s1815-6-965-x ASSISTED REPRODUCTION Does previous response to clomifene citrate influence the selection of gonadotropin dosage given in subsequent superovulation
More informationRelevance of LH activity supplementation
Relevance of LH activity supplementation in ovulation induction Franco Lisi Servizio di Fisiopatologia della Riproduzione Clinica Villa Europa Roma, Italia Comprehension of the role of LH in follicular
More informationEffect of ovarian stimulation on oocyte quality and embryonic aneuploidy: a prospective, randomised controlled trial
FULL PROJECT TITLE: Effect of ovarian stimulation on oocyte quality and embryonic aneuploidy: a prospective, randomised controlled trial (STimulation Resulting in Embryonic Aneuploidy using Menopur (STREAM)
More informationScientific Highlights: First world conference on luteinizing hormone in ART: Landing in Asia Pacific
This EXCEMED conference followed on from the First world conference on luteinizing hormone (LH) in ART, which took place in Naples in May 2016. Bringing the topic of LH to Asia Pacific provided an opportunity
More informationCurrent Evidence On Infertility Treatment
Current Evidence On Infertility Treatment Mahmoud A.M. Abdel-Aleem Regina Kulier WHO/GFMER 2003 Problem of Infertility It is a state in which a couple, desirous of a child, cannot conceive after 12 months
More informationInformation Booklet. Exploring the causes of infertility and treatment options.
Information Booklet Exploring the causes of infertility and treatment options www.ptafertility.co.za info@ptafertility.co.za +27 12 998 8854 Faith is taking the first step even if you don t see the whole
More informationPremature progesterone elevation impairs implantation and live birth rates in GnRH-agonist IVF/ICSI cycles
Arch Gynecol Obstet (2010) 281:747 752 DOI 10.1007/s00404-009-1248-0 REPRODUCTIVE MEDICINE Premature progesterone elevation impairs implantation and live birth rates in GnRH-agonist IVF/ICSI cycles Esra
More informationMenstruation-free interval and ongoing pregnancy in IVF using GnRH antagonists
Human Reproduction Vol.21, No.4 pp. 1012 1017, 2006 Advance Access publication December 8, 2005. doi:10.1093/humrep/dei415 Menstruation-free interval and ongoing pregnancy in IVF using GnRH antagonists
More informationOVULATION INDUCTION. Hsiang, Kaohsiung, Taiwan (FAX: ; adm.cgmh.org.tw).
OVULATION INDUCTION Significantly superior response in the right ovary compared with the left ovary after stimulation with follicle-stimulating hormone in a pituitary down-regulation regimen Kuo-Chung
More informationAbstract. Introduction. Materials and methods. Patients and methods
RBMOnline - Vol 8. No 3. 344-348 Reproductive BioMedicine Online; www.rbmonline.com/article/1178 on web 20 January 2004 Article Cumulative live birth rates after transfer of cryopreserved ICSI embryos
More informationOvarian Response to Gonadotrophin Stimulation in Patients with Previous Endometriotic Cystectomy
Ovarian Response to Gonadotrophin Stimulation in Patients with Previous Endometriotic Cystectomy M.E. Coccia, F. Cammilli, L. Ginocchini, F. Borruto* and F. Rizzello Dept Gynaecology Perinatology and Human
More informationAdvanced Assisted Reproductive Technologies
Advanced Assisted Reproductive Technologies 體外受孕中心 IVF Centre IVF CENTRE at Hong Kong Sanatorium & Hospital The IVF Centre at Hong Kong Sanatorium & Hospital has been offering excellent patient care and
More informationPreimplantation genetic diagnosis: polar body and embryo biopsy
Human Reproduction, Vol. 15, (Suppl. 4), pp. 69-75, 2000 Preimplantation genetic diagnosis: polar body and embryo biopsy Luca Gianaroli SISMER, Via Mazzini 12, 40138 Bologna, Italy Scientific Director
More informationCauses of Infertility and Treatment Options
Causes of Infertility and Treatment Options Dr Mrs.Kiran D. Sekhar Former vice President-FOGSI Former Chairperson- Genetics and Foetal medicine-fogsi Founder and Medical Director-Kiran Infertility centre
More informationRecent Developments in Infertility Treatment
Recent Developments in Infertility Treatment John T. Queenan Jr., MD Professor, Dept. Of Ob/Gyn University of Rochester Medical Center Rochester, NY Disclosures I don t have financial interest or other
More informationRealizing dreams booklet.indd 1 5/20/ :26:52 AM
Realizing dreams. 18891booklet.indd 1 5/20/2010 11:26:52 AM The Journey To Parenthood The first Gator Baby was born in 1988 through the in vitro fertilization program at the University of Florida. Since
More informationWOMEN & INFANTS HOSPITAL Providence, RI CONSENT FOR IN VITRO FERTILIZATION USING A GESTATIONAL CARRIER (PATIENT/INTENDED PARENTS) 1.
*40675* 40675 MR-838 (9-2017) WOMEN & INFANTS HOSPITAL Providence, RI 02905 CONSENT FOR IN VITRO FERTILIZATION USING A GESTATIONAL CARRIER (PATIENT/INTENDED PARENTS) 1. I, and (Print Patient s name) (Print
More informationBrighton & Hove CCG PLS CONFERENCE Dr Carole Gilling-Smith Medical Director
Brighton & Hove CCG PLS CONFERENCE 2016 Dr Carole Gilling-Smith Medical Director FERTILITY CHALLENGES IN THE NHS A TERTIARY CARE PERSPECTIVE LEARNING OBJECTIVES Understand the pathways through assisted
More informationOocyte maturity and preimplantation development in relation to follicle diameter in gonadotropin-releasing hormone agonist or antagonist treatments
IN VITRO FERTILIZATION Oocyte maturity and preimplantation development in relation to follicle diameter in gonadotropin-releasing hormone agonist or antagonist treatments Daniela Nogueira, Ph.D., a Shevach
More information2013 Sep.; 24(3):
Journal of Reproduction & Contraception doi: 10.7669/j.issn.1001-7844.2013.03.0151 2013 Sep.; 24(3):151-158 E-mail: randc_journal@163.com Reducing the Trigger Dose of Human Chorionic Gonadotrophin Does
More informationUW MEDICINE PATIENT EDUCATION. In Vitro Fertilization How to prepare and what to expect DRAFT
UW MEDICINE PATIENT EDUCATION In Vitro Fertilization How to prepare and what to expect This handout tells how to prepare for and what to expect when you go through a cycle of in vitro fertilization. It
More information